JEFFREY HARGRAVES: Open Payments
NPI 1053040493 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 47 payments from 19 companies in 2025. Trend: 2023 $72 · 2024 $69 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $247 |
| PFIZER INC. | 5 | $111 |
| Lilly USA, LLC | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Dexcom, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Corcept Therapeutics | 2 | $35 |
Products named: UBRELVY, QULIPTA, MOUNJARO, PREVNAR 20, Dexcom G6 Transmitter, REXULTI, GEMTESA, Auvelity.
Industry payments across ID — which companies pay providers there.
